UroCKDisS: Urologic-nephrological Care of Chronic Kidney Disease in Saxony-Anhalt/Magdeburg.

Sponsor
University of Magdeburg (Other)
Overall Status
Completed
CT.gov ID
NCT02229435
Collaborator
Medical Laboratory Schenk-Ansorge Magdeburg Germany. (Other)
1,031,336
1
116
8892.7

Study Details

Study Description

Brief Summary

Statement:

Patients with Chronic kidney disease (CKD) with an estimated glomerular filtration rate (eGFR) under 60 ml/min using the MDRD-6 (Modification of Diet in Renal Disease) formula and/or CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) formula should undergo nephrological and urological care (diagnosis and treatment) to prevent chronic kidney failure. This is recommended by the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI), Kidney Disease Improving Global Outcomes (KDIGO) and European Urological Association (EAU). Renal and postrenal diseases can cause or worsen CKD. Internistic and intrarenal diseases can caused or worsen CKD. All diseases affecting CKD should be treated and the medical care should be optimized.

Hypothesis:

Not all patients with CKD receive urological and nephrological care. Interdisciplinary work of outpatient working urologists and nephrologists in the metropolitan area Magdeburg / Saxony-Anhalt Germany is unknown. An descriptive analysis of interdisciplinary treatment connection of CKD patients for an orientating statement is needed.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The Medical Laboratory Schenk-Ansorge Magdeburg Saxony-Anhalt Germany receives all blood samples of outpatient patients of the medical practices of the metropolitan area Magdeburg Saxony-Anhalt Germany. Every patient has a lifetime identification number Independent of the submitting practice. Every submitting medical doctor has a lifetime identification number and is identified by her/his medical subject /specialization. This analysis is based on that laboratory database. For that study a cohort of 1.031.336 patients from 12/2004 to 08/2014 is evaluated, that had been received blood tests with measurement of serum creatinine. For every serum creatinine an eGGR is calculated with the guideline recommended formula.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    1031336 participants
    Observational Model:
    Cohort
    Official Title:
    Laboratory Database-based Analysis of the Interdisciplinary Urologic-nephrological Care of the Chronic Kidney Disease (CKD) With Estimated Glomerular Filtration Rate (eGFR) Under 60 ml/Min of the Population in Saxony-Anhalt / Metropolitan Area Magdeburg.
    Study Start Date :
    Dec 1, 2004
    Actual Primary Completion Date :
    Aug 1, 2014
    Actual Study Completion Date :
    Aug 1, 2014

    Arms and Interventions

    Arm Intervention/Treatment
    eGFR <60ml/min

    Patients with CKD with eGFR <60 ml/min (CKD-EPI or MDRD) 12/2004-08/2014 of Medical Laboratory, Prof. Schenk / Dr. Ansorge and Colleagues, GbR, Am Neustädter Feld 47, 39124 Magdeburg, Germany.

    Outcome Measures

    Primary Outcome Measures

    1. Chronic kidney disease [1 year]

      % of outpatient patients with eGFR < 60 ml/min and interdisciplinary urological and nephrological care in metropolitan area Magdeburg, Saxony-Anhalt, Germany.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Measured serum creatinine and estimated glomerular filtration rate

    • eGFR < 60 ml/min

    Exclusion Criteria:
    • dialysis

    • no serum creatinine measured

    • Age < 18 years

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Urology University Magdeburg Magdeburg Saxony-Anhalt Germany 39108

    Sponsors and Collaborators

    • University of Magdeburg
    • Medical Laboratory Schenk-Ansorge Magdeburg Germany.

    Investigators

    • Principal Investigator: Johann J Wendler, Dr., Urology University Magdeburg
    • Study Chair: Martin Schostak, Prof. Dr., Urology University Magdeburg
    • Study Director: Herwart Schenk, Prof. Dr., Medical Laboratory Am Neustädter Feld 47, 39124 Magdeburg, Saxony-Anhalt, Germany.
    • Principal Investigator: Constanze Tienken, Cand. med., Doctorand Urology University Magdeburg

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Johann J. Wendler, MD, Dr. med., University of Magdeburg
    ClinicalTrials.gov Identifier:
    NCT02229435
    Other Study ID Numbers:
    • URO-MD-040
    First Posted:
    Sep 1, 2014
    Last Update Posted:
    Sep 1, 2014
    Last Verified:
    Aug 1, 2014
    Keywords provided by Johann J. Wendler, MD, Dr. med., University of Magdeburg
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 1, 2014